Neurology Alert – November 1, 2013
November 1, 2013
View Issues
-
Clinical Briefs in Primary Care
Evidence-based updates in primary care medicine By Louis Kuritzky, MD -
Pharmacology Watch: Evidence-based updates in clinical pharmacology
Medications for Risk Reduction of Breast Cancer in Women -
Levetiracetam Is Not Better than Older Antiepileptic Drugs as Initial Monotherapy for Newly Diagnosed Epilepsy
In patients with newly diagnosed epilepsy, levetiracetam monotherapy was not superior to monotherapy with controlled-release carbamazepine or extended-release sodium valproate. -
Maternal Hypothyroxinemia and Autism
Very low levels of early-maternal free thyroxine are associated with a 4-fold increased risk of parental reports of autism symptoms in their offspring. -
Headaches A Hidden Disability Associated with Seizures
Periictal headaches are frequent, severe, and undertreated, and can be predicted by younger age at epilepsy onset, drug polytherapy, and tonic-clonic generalized seizures. -
Seizure Characteristics in Early-stage AD
This 5-year retrospective observational study describes the epilepsy encountered in patients with amnestic mild cognitive impairment and early Alzheimers disease. -
Botulinum Toxin for Postherpetic Neuralgia
In a small, placebo-controlled trial, botulinum toxin treatment showed a significant benefit for postherpetic neuralgia. -
Stroke Alert: A Review of Current Clinical Stroke Literature